Características clínicas y epidemiológicas de los pacientes con diagnóstico de tuberculosis multidrogorresistente en El Hospital Quillabamba 2012-2016.
View/ Open
Date
2018-06-19Author
Montes Rivera, Liz Vanessa
Advisor
Castro Chacón, Diana Felipa
Metadata
Show full item recordAbstract
El presente trabajo de investigación intitulado CARACTERÍSTICAS
CLÍNICAS Y EPIDEMIOLÓGICAS DE LOS PACIENTES CON
DIAGNÓSTICO DE TUBERCULOSIS MULTIDROGORRESISTENTE EN
EL HOSPITAL QUILLABAMBA 2012-2016
Cuyo objetivo fue determinar las características clínicas y epidemiológicas
de los pacientes con diagnóstico de tuberculosis multidrogorresistente
atendidos en el Hospital Quillabamba en los años 2012 a 2016; siendo un
estudio descriptivo, transversal, retrospectivo. La muestra estuvo
constituida por 36 Historias Clínicas completas de pacientes.
Llegando a los siguientes resultados 48.2% tuvo entre 30 a 59 años, 66.7%
fueron del sexo masculino, 42.4% convivientes, 51.4% con instrucción
Primaria, 94.4% tuvo trabajo independiente, 55.6% procede de la zona
urbana, 55.5% comparten entre 3 a 4 personas una habitación, 72.2%
nunca fue antes tratado por la tuberculosis, 55.6% tuvo contacto con otros
pacientes con diagnóstico de tuberculosis multidrogorresistente, 75%
presento tos más de 15 días, 50% presento tos con expectoración
hemoptoica, 77.7% presento sudoración nocturna, 61.2% no presento
fiebre, 66.5% no presento bajo peso, 41.8% tuvo aparentemente buen
estado general, 69.4% no presento anemia, 50.1% tuvo apetito normal,
47.2% presento otras comorbilidades, 83.4% el medio de diagnóstico fue
bacteriológico y radiológico, 61.2% su estado nutricional fue normal, 69.4%
recibió el esquema de tratamiento empírico, 63.8% presento drogo
resistencia a Isoniacida y Rifampicina, 75% su condición de alta fue curado. This research paper titled CLINICAL AND EPIDEMIOLOGICAL OF
PATIENTS WITH TUBERCULOSIS MULTIDRUG RESISTAND IN
QUILLABAMBA HOSPITAL 2012-2016
The objective was to determine the clinical and epidemiological
characteristics of patients diagnosed with multidrug-resistant tuberculosis
treated at the Hospital in Quillabamba from 2012 to 2016; being a
descriptive, transversal, retrospective study. The clinical trial consisted of 36
patients with complete medical history.
The following results were met , 48.2% were between 30 and 59 years old,
66.7% were male, 42.4% were cohabitants, 51.4% had primary education,
94.4% had independent work, 55.6% came from urban areas, 55.5%
shared between 3 to 4 people in a room, 72.2% were never treated before
for tuberculosis, 55.6% had contact with other patients with multidrugresistant
tuberculosis,
75%
had
a
cough,
50%
presented
with
expectoration
hemoptica,
77.7% were presented with night sweats, 61.2% had fevers,
66.5% did not present low weight, 41.8% had apparently a good general
condition, 69.4% did not have anemia, 50.1% had normal appetite, 47.2%
presented other comorbidities, in 83.4 % the means of diagnosis was
bacteriological, 61.2% its nutritional status was normal, 69.4% received the
empirical treatment scheme, 63.8% presented drug resistance to Isonic and
Rifampicin, 75% their condition of discharge was cured.